<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F1D1CEC4-C1D4-4B6C-9629-E4522EFDA6E2"><gtr:id>F1D1CEC4-C1D4-4B6C-9629-E4522EFDA6E2</gtr:id><gtr:firstName>Sten</gtr:firstName><gtr:otherNames>Eirik</gtr:otherNames><gtr:surname>Jacobsen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12009%2F5"><gtr:id>7E7E0C75-3511-4676-93A6-7058031769B7</gtr:id><gtr:title>Understanding cell fate decisions in normal and abnormal haematopoiesis</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12009/5</gtr:grantReference><gtr:abstractText>The research programme in the Jacobsen laboratory aims to improve our understanding of how development of the different blood cell lineages occurs from blood forming stem cells in the adult bone marrow and in the embryo. A main focus is to understand the molecular regulation of these processes with the goal of identifying pathways which can be used to enhanced regeneration of specific blood lineages in clinical settings. Another main focus is to understand how the blood forming stem and progenitor cells as well as key signalling pathways regulating them, are perturbed in leukaemia and other haematological malignancies, with the goal of identifying new therapeutic targets at the cellular and molecular level. These research questions will be pursued in mouse models of normal and leukaemic haematopoiesis, as well as through studies of normal and leukaemic stem cells from human subjects.</gtr:abstractText><gtr:technicalSummary>The research in the Jacobsen laboratory will remain focussed at obtaining a better understanding of the cellular pathways of normal lineage commitment from multipotent HSCs to lineage-restricted progenitors. However, in the coming years, while devoting an increasing emphasis on unravelling the molecular determinants of the now established lineage commitment steps in the earliest stages of lympho-myelopoiesis in adult haematopoiesis, an increasing effort will be devoted towards identifying and characterising the earliest stages of lineage commitment in the embryo. Furthermore, with an increasing understanding of lineage commitment steps in normal haematopoiesis, the Jacobsen laboratory will with support of the strong mouse genetics efforts within the MHU, embark on new research lines, in which the goal is to understand the impact of distinct pre-leukaemic and leukaemic mutations on distinct stages of lineage commitment. Finally, the laboratory will continue their efforts to uncover the cellular and molecular determinants of the haematopoietic defects in MDS, and its transformation to AML.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1195000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Adam Mead</gtr:description><gtr:id>B26F5605-B261-4789-98DA-DFF40B597011</gtr:id><gtr:impact>Multiple publications listed in outcome</gtr:impact><gtr:outcomeId>56e15cf8a0bcd8.40319398-1</gtr:outcomeId><gtr:partnerContribution>Molecular analysis of hematopoiesis</gtr:partnerContribution><gtr:piContribution>Mouse models of normal and malignant hematopoiesis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Andrew Smith</gtr:description><gtr:id>6E9BE5A5-3643-42D4-8D8D-6048346A8659</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>56e15e3859a4e0.30208384-1</gtr:outcomeId><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>-</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Claus Nerlov</gtr:description><gtr:id>EA496B0A-CCFF-4571-BC26-55C5C2092DB3</gtr:id><gtr:impact>As listed in outcome multiple high impact joint publications</gtr:impact><gtr:outcomeId>56e15cc8390437.40710254-1</gtr:outcomeId><gtr:partnerContribution>Mouse genetic models of normal and malignant hematopoiesis</gtr:partnerContribution><gtr:piContribution>stem and progenitor cell characterisation</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Marella de Bruijn</gtr:description><gtr:id>CC3F4309-FC84-445F-A642-2C4F3329264F</gtr:id><gtr:impact>Several publications, including Boiers et al, Cell Stem Cell 2013 and Luc et al, Nature Immunology 2012</gtr:impact><gtr:outcomeId>56e15d68107dc7.34079762-1</gtr:outcomeId><gtr:partnerContribution>Expertise in mouse developmental hematopoiesis</gtr:partnerContribution><gtr:piContribution>Mouse Models for stem and progenitor biology</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Rickard Sandberg</gtr:description><gtr:id>9B47E6F5-DC1C-4F06-AB54-62967C42DCF6</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>56e15f95020361.28455785-1</gtr:outcomeId><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>-</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Anna Katharina (Katja) Simon</gtr:description><gtr:id>63CFF0F6-E71C-4154-99EB-3775C50E3003</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>56e15e9ed77023.98929604-1</gtr:outcomeId><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>-</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute for Medical Research (CIMR)</gtr:department><gtr:description>Anthony (Tony) Green</gtr:description><gtr:id>4A20EF66-5CE1-4F68-9A92-957B5EA7D4A6</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>56e160fba1bbb5.99242188-1</gtr:outcomeId><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>-</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Sten Linnarsson</gtr:description><gtr:id>42959A7A-D3AC-49B7-BDE1-0C55C8C90219</gtr:id><gtr:impact>Publications as listed above</gtr:impact><gtr:outcomeId>56e15fdee60d40.49523541-1</gtr:outcomeId><gtr:partnerContribution>Sten Linnarsson is a world leader in single cell RNA sequencing and his input has been key to several of our reported publications utilising small cell number or single cell RNA sequencing (Cell Stem Cell 2013; Cancer Cell 2014)</gtr:partnerContribution><gtr:piContribution>Single cell analysis of stem and progenitor cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Geissmann F.</gtr:description><gtr:id>7876BA36-A8FF-4187-8C12-F13E8A968584</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>56e15fb954a1c7.64922389-1</gtr:outcomeId><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>-</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>10000000</gtr:amountPounds><gtr:country>Sweden, Kingdom of</gtr:country><gtr:currCode>SEK</gtr:currCode><gtr:currCountryCode>Sweden</gtr:currCountryCode><gtr:currLang>sv_SE</gtr:currLang><gtr:description>Tobias Award</gtr:description><gtr:fundingOrg>Tobias Foundation</gtr:fundingOrg><gtr:id>64DEBBD5-F04A-46A4-9608-F567772E1D00</gtr:id><gtr:outcomeId>56bc96a850c1a1.85599958</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>93000000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>SEK</gtr:currCode><gtr:currCountryCode>Sweden</gtr:currCountryCode><gtr:currLang>sv_SE</gtr:currLang><gtr:description>Establishment of Hematopoietic Stem Cell Research Program at the Karolinska Institute</gtr:description><gtr:fundingOrg>Swedish Research Council</gtr:fundingOrg><gtr:id>655E7CF1-10BD-460F-AF0A-9B8A307D49AA</gtr:id><gtr:outcomeId>56bc96eca006c6.28890507</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000000</gtr:amountPounds><gtr:country>Sweden, Kingdom of</gtr:country><gtr:currCode>SEK</gtr:currCode><gtr:currCountryCode>Sweden</gtr:currCountryCode><gtr:currLang>sv_SE</gtr:currLang><gtr:description>Professor/ Prize in Medicine 2015</gtr:description><gtr:end>2025-12-02</gtr:end><gtr:fundingOrg>Torsten S?derbergs Stiftelse</gtr:fundingOrg><gtr:id>13DF0948-954E-4C25-B250-ADAACC4B4BA2</gtr:id><gtr:outcomeId>58ad65379e3656.77109916</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>John Fell Fund</gtr:department><gtr:description>Acquisition of high-end FACS cell sorter for WIMM FACS facility.</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>88EA4E44-7E6D-4D40-8983-C8A819AD85BB</gtr:id><gtr:outcomeId>56bc97434c34d3.09601876</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Molecular Haematology Unit</gtr:department><gtr:description>Characterisation and regulation of distinct hematopoietic stem and progenitor cells</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B0839860-1B7C-48C2-9D8B-1E000EDD8582</gtr:id><gtr:outcomeId>56d59a8aed1287.33010740</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chairman of Committee for allogeneic transplantations and cell therapies, Karolinska University Hospital</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1CFB94C7-4D3E-40A9-97B0-1BAAC014528E</gtr:id><gtr:impact>Allogeneic transplantations and cell therapies.</gtr:impact><gtr:outcomeId>56d95f4a8466a8.84635231</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Board of Center of Excellence in Developmental Biology, Karolinska Institute</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2F7170DD-9B1F-4255-AFA9-24B22253B864</gtr:id><gtr:impact>Member of Board of Center of Excellence in Developmental Biology, Karolinska Institute (Director, Professor Urban Lendahl)</gtr:impact><gtr:outcomeId>56d961ff249bb8.63587219</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>International Society for Stem Cell Research (ISSCR) McEwen Award for Innovation selection committee</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>C957B601-6536-4EFB-AF31-AC6F1D9BB6FA</gtr:id><gtr:impact>International Society for Stem Cell Research (ISSCR) McEwen Award for Innovation selection committee</gtr:impact><gtr:outcomeId>56d96038e014d2.43728503</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.isscr.org</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Board of Center for Molecular Medicine, Karolinska Institutet</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>811E852C-78CF-40F8-8000-23BAAA815520</gtr:id><gtr:impact>Member of Board of Center for Molecular Medicine, Karolinska Institutet</gtr:impact><gtr:outcomeId>56d95edb7671f2.68394200</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Permanent member of Cell and Developmental Biology Expert Review Group, Wellcome Trust</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>8C14DC54-66B5-4117-BBE4-612FFE59D1A1</gtr:id><gtr:outcomeId>58ad68336d5f67.00937730</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Scientific Advisory Board, Stem Cell Institute, Leuven, Belgium</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8D127C3E-C3CD-4833-91D9-AA3C97EC7C76</gtr:id><gtr:impact>Member of Scientific Advisory Board, Stem Cell Institute, Leuven, Belgium (Director Professor Catherine Verfaillie) - Starting date 2005-date</gtr:impact><gtr:outcomeId>56d96109de1fb0.22149005</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.kuleuven.be/samenwerking/scil</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>OX Stem Oncology</gtr:companyName><gtr:description>Establishment (as co-founder) of a spin-off company for development of targeting of cancer stem cells.</gtr:description><gtr:id>C9820FE9-3049-4568-B416-8D08FBD8252E</gtr:id><gtr:impact>Development of therapeutic targeting of cancer stem cells.</gtr:impact><gtr:outcomeId>56e16ac42cc651.45742534</gtr:outcomeId><gtr:yearCompanyFormed>2016</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>A7541DA8-CDBB-4F77-BFEA-915CF3D2CCE6</gtr:id><gtr:title>Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/884a8401cd72205f42779a840d6a93a3"><gtr:id>884a8401cd72205f42779a840d6a93a3</gtr:id><gtr:otherNames>Grover A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>54513c2e385657.44030317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A00DF28-1F8C-46A2-803F-63A5E7B5A6B3</gtr:id><gtr:title>Dicer is selectively important for the earliest stages of erythroid development.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/867a455fe097c2dfa583641b7668df6a"><gtr:id>867a455fe097c2dfa583641b7668df6a</gtr:id><gtr:otherNames>Buza-Vidas N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>jmYu2gVNtQ8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57EF141A-7766-405C-8520-E388FEC1FAFC</gtr:id><gtr:title>Impact of isolated germline JAK2V617I mutation on human hematopoiesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fb12a98d4056670ebefede87ebda6ba"><gtr:id>5fb12a98d4056670ebefede87ebda6ba</gtr:id><gtr:otherNames>Mead AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_16493_23_23535062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE970759-D45D-42B2-93CD-6526CB2271D7</gtr:id><gtr:title>Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/884a8401cd72205f42779a840d6a93a3"><gtr:id>884a8401cd72205f42779a840d6a93a3</gtr:id><gtr:otherNames>Grover A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56e15a9d8c7259.24758013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>466C5F95-6F79-4576-B5D0-0D2D2994339F</gtr:id><gtr:title>Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c678f61d9baba78039fd689d1985a666"><gtr:id>c678f61d9baba78039fd689d1985a666</gtr:id><gtr:otherNames>Woll PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>54513c2e975000.89223367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8D770AE-ABDF-47F8-9CAB-348CC905A8BC</gtr:id><gtr:title>Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c898c712828706075492c628cb10fce"><gtr:id>5c898c712828706075492c628cb10fce</gtr:id><gtr:otherNames>Drissen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>56e15b084f8526.61479648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>142B6874-7703-493A-B9D8-D5DB693C6664</gtr:id><gtr:title>The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/863c8044fc8bc8103f03fb2384b7e08c"><gtr:id>863c8044fc8bc8103f03fb2384b7e08c</gtr:id><gtr:otherNames>Luc S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>ErYc6g43LJJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8191F94D-FFA0-4FF7-8C00-394F57909F66</gtr:id><gtr:title>Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dcbcbb174ef85060f893c5185d2dbd0"><gtr:id>9dcbcbb174ef85060f893c5185d2dbd0</gtr:id><gtr:otherNames>Sanjuan-Pla A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_16493_23_23934107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA0C6DC2-2EC4-4927-889A-4827104300B9</gtr:id><gtr:title>A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B&amp;nbsp;Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5020f1fc79f56da95e57541d9bb5da4"><gtr:id>d5020f1fc79f56da95e57541d9bb5da4</gtr:id><gtr:otherNames>B?iers C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>5a6f2fa8060e39.30823312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C73999B-A93B-44C1-8FE8-DFA234F4239E</gtr:id><gtr:title>Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f038c872ebeffbfe50f3aa1d06b051c"><gtr:id>3f038c872ebeffbfe50f3aa1d06b051c</gtr:id><gtr:otherNames>Carrelha J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a8fdf54639547.34747011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6FA3F8F-FEBA-4534-8470-7F5AE32D7A48</gtr:id><gtr:title>FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fb12a98d4056670ebefede87ebda6ba"><gtr:id>5fb12a98d4056670ebefede87ebda6ba</gtr:id><gtr:otherNames>Mead AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_16493_23_23727242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39FC36D5-F5B8-43CF-9AD1-493BF6FF3C15</gtr:id><gtr:title>Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1728ccec91fe45aa3d33d427207f9037"><gtr:id>1728ccec91fe45aa3d33d427207f9037</gtr:id><gtr:otherNames>Lutz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn><gtr:outcomeId>54513c2dc8d354.06241355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A38E79E-EF7F-4F29-8B2D-90F392B6367A</gtr:id><gtr:title>Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5020f1fc79f56da95e57541d9bb5da4"><gtr:id>d5020f1fc79f56da95e57541d9bb5da4</gtr:id><gtr:otherNames>B?iers C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_16493_23_24054998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3347E28-9381-48D1-A2CA-FC8FDAABFDD6</gtr:id><gtr:title>In&amp;nbsp;Vivo Labeling by CD73 Marks Multipotent Stromal Cells and Highlights Endothelial Heterogeneity in the Bone Marrow Niche.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69e0ffc6c8d9d2acbe55ee2a9725ba3f"><gtr:id>69e0ffc6c8d9d2acbe55ee2a9725ba3f</gtr:id><gtr:otherNames>Breitbach M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>5a8fdf54a1ff28.18052440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF392BF7-D8A8-41A9-8957-84D39EB68AEB</gtr:id><gtr:title>Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitors.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bc2a33653d404809acfd047a1a3aa3c"><gtr:id>6bc2a33653d404809acfd047a1a3aa3c</gtr:id><gtr:otherNames>Luis TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58ac5eecdb8e93.25725841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>514B4E89-0D69-45A0-BCB4-1BFC40259910</gtr:id><gtr:title>Autophagy-Dependent Generation of Free Fatty Acids Is Critical for Normal Neutrophil Differentiation.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1884bb7112600531185acda94f93cff9"><gtr:id>1884bb7112600531185acda94f93cff9</gtr:id><gtr:otherNames>Riffelmacher T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>5a360d3248cab9.89374774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C97B0CD-3AAB-43DD-9534-2354311D0914</gtr:id><gtr:title>A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e241df9506cc57c225f4d67f9f5101c"><gtr:id>5e241df9506cc57c225f4d67f9f5101c</gtr:id><gtr:otherNames>Buono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>56d59566f0df90.30552834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>927C7B06-EA19-4012-83D7-3750537C0596</gtr:id><gtr:title>Transcriptional repression of Gata3 is essential for early B cell commitment.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/384b11b2c521a3ead015d219baa5bdbc"><gtr:id>384b11b2c521a3ead015d219baa5bdbc</gtr:id><gtr:otherNames>Banerjee A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>pm_16493_23_23684985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>158E17FC-C650-46E7-9FE1-5D50FEF0C82C</gtr:id><gtr:title>Canonical Notch signaling is dispensible for adult steady-state and stress myelo-erythropoiesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d78891d2f107dd298042f7e634936e4f"><gtr:id>d78891d2f107dd298042f7e634936e4f</gtr:id><gtr:otherNames>Duarte S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5a8fdf54c4ec20.05219144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DA1A961-FE4D-4E11-A3FA-F40976F3AE27</gtr:id><gtr:title>Macrophage colony-stimulating factor receptor marks and regulates a fetal myeloid-primed B-cell progenitor in mice.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77b898934872e74bda9b511e73d71ee7"><gtr:id>77b898934872e74bda9b511e73d71ee7</gtr:id><gtr:otherNames>Zriwil A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>585d6c2fca2892.72115144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43A4BA7D-1876-40BE-B806-AE64E28395D9</gtr:id><gtr:title>Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c0faa31efcd24f8bdfa70eb424caae9"><gtr:id>9c0faa31efcd24f8bdfa70eb424caae9</gtr:id><gtr:otherNames>Dimitriou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58ac5e575ea494.76111003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7572CDB0-4603-4E4B-8AE1-CE7B5D8F3E1B</gtr:id><gtr:title>Characterization of transcriptional networks in blood stem and progenitor cells using high-throughput single-cell gene expression analysis.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e43ddbaffb2536bea263c184f18dd8f"><gtr:id>0e43ddbaffb2536bea263c184f18dd8f</gtr:id><gtr:otherNames>Moignard V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_16493_23_23524953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>412673B0-D1F3-4DFE-B46E-E1A1A5EF5283</gtr:id><gtr:title>Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fb12a98d4056670ebefede87ebda6ba"><gtr:id>5fb12a98d4056670ebefede87ebda6ba</gtr:id><gtr:otherNames>Mead AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5a2fd347aa71a6.86962895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BAA2C4D-ABA8-43A5-B545-A7F5BAD9EB78</gtr:id><gtr:title>A lineage of myeloid cells independent of Myb and hematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6611fb1d82a723ab6d7bd458727956ee"><gtr:id>6611fb1d82a723ab6d7bd458727956ee</gtr:id><gtr:otherNames>Schulz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_16493_23_22442384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F3A7A6B-C0E1-4BE4-B504-02D6C407E2C3</gtr:id><gtr:title>Primitive Embryonic Macrophages are Required for Coronary Development and Maturation.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a745ead6e86499980d0b10512f52e0cb"><gtr:id>a745ead6e86499980d0b10512f52e0cb</gtr:id><gtr:otherNames>Leid J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>58ac5eed0669e2.72125345</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12009/5</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>